Literature DB >> 8341646

Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection.

C Graziosi1, G Pantaleo, L Butini, J F Demarest, M S Saag, G M Shaw, A S Fauci.   

Abstract

HIV-1 replication and viral burden in peripheral blood mononuclear cells (PBMC) have been reported to be high in primary infection but generally very low during the prolonged period of clinical latency. It is uncertain precisely when this transition occurs during the HIV-1 infection and what the relationship is between the changes in HIV-1 replication versus the clearance of infected cells in the overall control of viral replication. In the present study, the kinetics of viral burden (i.e., frequency of HIV-1-infected cells) and replication during primary and early-chronic infection were analyzed in PBMC of four acutely infected individuals. High frequencies of HIV-1-infected cells and high levels of virus replication were observed in PBMC after primary HIV-1 infection. Down-regulation of virus replication in PBMC was observed in all four patients coincident with the emergence of HIV-1-specific immune responses. Other parameters of virus replication, such as circulating plasma p24 antigen and plasma viremia showed similar kinetics. In contrast, a significant decline in viral burden in PBMC was observed in only one of four patients. These results indicate that the down-regulation in the levels of virus replication associated with the clinical transition from acute to chronic infection does not necessarily reflect a reduction in viral burden, thus suggesting the involvement of additional factors. Identification of these factors will be important in elucidating the host mechanisms involved in the early control of HIV-1 infection and disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8341646      PMCID: PMC46940          DOI: 10.1073/pnas.90.14.6405

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Frequent detection of HIV-1-specific mRNAs in infected individuals suggests ongoing active viral expression in all stages of disease.

Authors:  S M Schnittman; J J Greenhouse; H C Lane; P F Pierce; A S Fauci
Journal:  AIDS Res Hum Retroviruses       Date:  1991-04       Impact factor: 2.205

2.  Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study.

Authors:  N M Graham; S L Zeger; L P Park; J P Phair; R Detels; S H Vermund; M Ho; A J Saah
Journal:  Lancet       Date:  1991-08-03       Impact factor: 79.321

Review 3.  The immunopathogenesis of human immunodeficiency virus infection.

Authors:  G Pantaleo; C Graziosi; A S Fauci
Journal:  N Engl J Med       Date:  1993-02-04       Impact factor: 91.245

Review 4.  The effect of cytokines and pharmacologic agents on chronic HIV infection.

Authors:  G Poli; A S Fauci
Journal:  AIDS Res Hum Retroviruses       Date:  1992-02       Impact factor: 2.205

5.  High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.

Authors:  M Piatak; M S Saag; L C Yang; S J Clark; J C Kappes; K C Luk; B H Hahn; G M Shaw; J D Lifson
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

6.  Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS.

Authors:  J Embretson; M Zupancic; J L Ribas; A Burke; P Racz; K Tenner-Racz; A T Haase
Journal:  Nature       Date:  1993-03-25       Impact factor: 49.962

7.  HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease.

Authors:  G Pantaleo; C Graziosi; J F Demarest; L Butini; M Montroni; C H Fox; J M Orenstein; D P Kotler; A S Fauci
Journal:  Nature       Date:  1993-03-25       Impact factor: 49.962

Review 8.  CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review.

Authors:  D S Stein; J A Korvick; S H Vermund
Journal:  J Infect Dis       Date:  1992-02       Impact factor: 5.226

9.  The effect of antiviral therapy on the natural history of human immunodeficiency virus infection in a cohort of hemophiliacs.

Authors:  M V Ragni; L A Kingsley; S J Zhou
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992

10.  Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus.

Authors:  T M Folks; D Powell; M Lightfoote; S Koenig; A S Fauci; S Benn; A Rabson; D Daugherty; H E Gendelman; M D Hoggan
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

View more
  27 in total

1.  Increase in dendritic cell numbers, their function and the proportion uninfected during AZT therapy.

Authors:  M Gompels; S Patterson; M S Roberts; S E Macatonia; A J Pinching; S C Knight
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

Review 2.  Study of the T cell receptor repertoire in viral immunodeficiency disease.

Authors:  C Ciurli; R P Sékaly; H Soudeyns
Journal:  Springer Semin Immunopathol       Date:  1996

Review 3.  Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection.

Authors:  M Clementi; S Menzo; P Bagnarelli; A Valenza; S Paolucci; R Sampaolesi; A Manzin; P E Varaldo
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

4.  Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection.

Authors:  G Pantaleo; H Soudeyns; J F Demarest; M Vaccarezza; C Graziosi; S Paolucci; M Daucher; O J Cohen; F Denis; W E Biddison; R P Sekaly; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

5.  Infection of primary human microglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: evidence of differential tropism.

Authors:  J M Strizki; A V Albright; H Sheng; M O'Connor; L Perrin; F González-Scarano
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

6.  An acutely lethal simian immunodeficiency virus stimulates expansion of V beta 7- and V beta 14-expressing T lymphocytes.

Authors:  Z W Chen; Z C Kou; L Shen; J D Regan; C I Lord; M Halloran; D Lee-Parritz; P N Fultz; N L Letvin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

7.  Selection of recombinant, library-derived antibody fragments against p24 for human immunodeficiency virus type 1 diagnostics.

Authors:  H J de Haard; B Kazemier; M J Koolen; L J Nijholt; R H Meloen; B van Gemen; H R Hoogenboom; J W Arends
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

8.  Viral load and CD4+ T-cell dynamics in primary HIV-1 subtype C infection.

Authors:  Vladimir Novitsky; Elias Woldegabriel; Lemme Kebaabetswe; Raabya Rossenkhan; Busisiwe Mlotshwa; Caitlin Bonney; Mariel Finucane; Rosemary Musonda; Sikhulile Moyo; Carolyn Wester; Erik van Widenfelt; Joseph Makhema; Stephen Lagakos; M Essex
Journal:  J Acquir Immune Defic Syndr       Date:  2009-01-01       Impact factor: 3.731

9.  Plasma viral RNA load predicts disease progression in accelerated feline immunodeficiency virus infection.

Authors:  L J Diehl; C K Mathiason-Dubard; L L O'Neil; E A Hoover
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  Relationship between tumor necrosis factor alpha and feline immunodeficiency virus expressions.

Authors:  L A Kraus; W G Bradley; R W Engelman; K M Brown; R A Good; N K Day
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.